Skip to content

Worrying concerns over AstraZeneca Covid vaccine as patients in Denmark develop blood clots

A number of patients in Denmark have developed blood clots after receiving covid vaccine shots by AstraZeneca leading to the vaccine being suspended. The Danish Health Authority on Thursday temporarily halted the use of AstraZeneca coronavirus vaccine.

The Danish Health Authority stopped short of saying there was a direct link between the AstraZeneca covid vaccine and the blood clots.

6 other European countries halt AstraZeneca covid vaccine use

A further six European countries have halted the use of a vaccine batch from AstraZeneca, the Danish authorities said.

Austria has stopped using a batch of AstraZeneca shots while investigating a death from coagulation disorders and an illness from a pulmonary embolism.

The Danish Medicines Agency claimed it had launched an investigation into the vaccine and the investigation is being carried out by corresponding agencies in other EU countries as well as the European Medicines Agency (EMA).

The EMA is in charge of the evaluation and supervision of medicinal products in the EU bloc reported DW.

READ MORE: Germany: “Astra Zeneca COVID vaccine only for people under 65” – Jens Spahn

Germany. ‘Flu-like symptoms’ after AstraZeneca vaccine. Hospitals suspend vaccinations in North Rhine-Westphalia

“Both we and the Danish Medicines Agency have to respond to reports of possible serious side-effects, both from Denmark and other European countries,” the director of the Danish Health Authority, Soren Brostrom, said in a statement.

AstraZeneca Vaccine could be useless against some strains

The vaccine developed by the British-Swedish pharmaceutical company has already generated concerns over its efficiency in other countries. In Germany, many of the vaccine doses developed by the firm are going unused due to worries that it is less effective against virus mutations.

Because of a lack of studies into its effects on older people, the AstraZeneca covid vaccine has been approved in Germany for people younger than 65. ( we wrote about it HERE.)

Source: DW,